NKAIN4 (sodium/potassium transporting ATPase interacting 4) is a protein involved in sodium ion transport regulation through interaction with the Na+/K+-ATPase. Based on GO annotations, NKAIN4 functions as a regulatory protein binding partner that modulates sodium transport mechanisms [Gene Ontology]. The molecular mechanism involves protein-protein interactions that fine-tune ion pump activity, though detailed mechanistic studies are limited in the available literature. Disease relevance of NKAIN4 spans multiple conditions. In acute lymphoblastic leukemia, a novel NKAIN4::PNPLA7 fusion gene was identified as an emerging genetic alteration in B-cell precursor ALL, representing one of six novel rearrangements discovered through RNA-sequencing in a cohort of pediatric B-other ALL patients 1. In colon adenocarcinoma, NKAIN4 was identified as a target gene regulated by hsa-miR-4709 within a competing endogenous RNA network associated with recurrence risk, suggesting involvement in tumorigenesis pathways 2. Furthermore, a genetic variant near NKAIN4 showed significant sex-specific association with COPD risk in males from the Canadian Longitudinal Study on Aging, indicating NKAIN4's relevance to respiratory disease pathophysiology 3. Clinically, NKAIN4 emerges as a potential biomarker in cancer prognosis and respiratory disease risk stratification, though its specific therapeutic targeting remains underdeveloped.